DANNCE.AI (Pre-seed)
Funding Details
- Awarder
- Inbox
- Date Award
- November 21, 2024
- Vertical
- Healthcare Technology
- Funding URL
- View Funding Page
- Funding Amount:
- $2,600,000
Company Info
- Founders
- Dr. Tim Dunn, Dr. Jesse Marshall, Rob Baldoni
- Company Description
- DANNCE.AI is developing an AI biomarkers platform called DANNCE that digitizes clinical assessments to quantify movement and evaluate drug efficacy for neurological disorders. The platform uses AI to analyze patient videos and provides objective assessments, improving clinical decision-making and drug development.
- Market
- Neurological Care and Drug Development
- Location
- Boston, Massachusetts, United States
- Coinvestors
- Glasswing Ventures, The Leo Lion Company, Duke Capital Partners, Merck Digital Sciences Studio